###begin article-title 0
###xml 76 80 <span type="species:ncbi:10090">mice</span>
TAK1 is required for the survival of hematopoietic cells and hepatocytes in mice
###end article-title 0
###begin p 1
###xml 25 40 25 40 <email xmlns:xlink="http://www.w3.org/1999/xlink">jzhang@lumc.edu</email>
CORRESPONDENCE J. Zhang: jzhang@lumc.edu
###end p 1
###begin p 2
This article is distributed under the terms of an Attribution-Noncommercial-Share Alike-No Mirror Sites license for the first six months after the publication date (see ). After six months it is available under a Creative Commons License (Attribution-Noncommercial-Share Alike 3.0 Unported license, as described at ).
###end p 2
###begin p 3
###xml 320 321 309 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 596 600 585 589 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 957 961 946 950 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 650 654 <span type="species:ncbi:10090">mice</span>
Transforming growth factor beta-activated kinase 1 (TAK1), a member of the MAPKKK family, is a key mediator of proinflammatory and stress signals. Activation of TAK1 by proinflammatory cytokines and T and B cell receptors induces the nuclear localization of nuclear factor kappaB (NF-kappaB) and the activation of c-Jun N-terminal kinase (JNK)/AP1 and P38, which play important roles in mediating inflammation, immune responses, T and B cell activation, and epithelial cell survival. Here, we report that TAK1 is critical for the survival of both hematopoietic cells and hepatocytes. Deletion of TAK1 results in bone marrow (BM) and liver failure in mice due to the massive apoptotic death of hematopoietic cells and hepatocytes. Hematopoietic stem cells and progenitors were among those hematopoietic cells affected by TAK1 deletion-induced cell death. This apoptotic cell death is autonomous, as demonstrated by reciprocal BM transplantation. Deletion of TAK1 resulted in the inactivation of both JNK and NF-kappaB signaling, as well as the down-regulation of expression of prosurvival genes.
###end p 3
###begin p 4
###xml 171 172 171 172 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 201 202 201 202 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 206 207 206 207 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 212 213 212 213 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 232 233 232 233 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 237 238 237 238 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 243 244 243 244 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
Abbreviations used: APC, allophycocyanin; CP, committed hematopoietic progenitor; Hb, hemoglobin; HSC, hematopoietic stem cell; HSC/P, HSC and progenitor cell; JNK, c-Jun N-terminal kinase; LK, lineage-Sca1-c-kit+ cell; LSK, lineage-Sca1+c-kit+ cell; plt, platelet number; polyI:C, polyinosinic:polycytidylic acid; TAK1, TGF-beta-activated kinase 1; TNC, total nucleated cell number; TUNEL, terminal deoxynucleotidyltransferase-mediated UTP end-labeling; WBC, white blood cell.
###end p 4
###begin p 5
M. Tang, X. Wei, and Y. Guo contributed equally to this paper.
###end p 5
###begin p 6
X. Wei's present address is Henan Tumor Hospital, 127 Dongming Road, Zhengzhou 450008, China.
###end p 6
###begin p 7
Y. Guo's present address is Dept. of Respiratory and Molecular Biology, Renji Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 200127, China.
###end p 7
###begin p 8
###xml 415 416 415 416 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib1">1</xref>
###xml 417 418 417 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib3">3</xref>
###xml 547 548 547 548 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib4">4</xref>
###xml 550 551 550 551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib5">5</xref>
###xml 593 594 593 594 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib6">6</xref>
###xml 611 612 607 608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib7">7</xref>
###xml 703 704 699 700 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib1">1</xref>
###xml 705 706 701 702 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib3">3</xref>
###xml 757 758 749 750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib8">8</xref>
###xml 774 775 763 764 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib9">9</xref>
###xml 801 803 790 792 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib10">10</xref>
###xml 1089 1090 1078 1079 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib1">1</xref>
###xml 1091 1092 1080 1081 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib3">3</xref>
A proper level of apoptosis is required for the maintenance of normal hematopoietic homeostasis by removing aged or abnormal cells. The balance between proapoptotic and antiapoptotic mechanisms is tightly controlled in hematopoietic cells, including hematopoietic stem cells (HSCs) and progenitor cells (HSC/Ps) by intrinsic signals that are subject to regulation by signals emanating from the BM microenvironment (1-3). Hematopoietic cytokines such as stem cell factor, IL-3, and thrombopoietin provide a survival signal for hematopoietic cells (4, 5) by inducing the activation of PI3K/AKT (6) and NF-kappaB (7) signaling, and by up-regulating antiapoptotic genes, such as members of the Bcl2 family (1-3). Proinflammatory cytokines, including TNF-alpha (8) and IL-1beta (9), as well as Fas ligand (10), all mediate dual signals for HSC/P functions. A negative signal induces programmed cell death and/or differentiation, whereas a positive signal promotes proliferation and survival. Disruption of this balance will result in hematopoietic disorders, including BM failure and leukemia (1-3).
###end p 8
###begin p 9
###xml 92 94 89 91 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib11">11</xref>
###xml 349 350 342 343 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 380 382 373 375 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib11">11</xref>
###xml 471 473 464 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib12">12</xref>
###xml 716 718 709 711 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib13">13</xref>
###xml 719 721 712 714 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib16">16</xref>
###xml 952 954 945 947 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib17">17</xref>
###xml 956 958 949 951 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib18">18</xref>
###xml 1070 1072 1063 1065 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib10">10</xref>
###xml 1074 1076 1067 1069 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib19">19</xref>
TGF-beta-activated kinase 1 (TAK1) is a key mediator of stress and proinflammatory signals (11). The proinflammatory cytokines induce both proapoptotic and antiapoptotic signals in their target cells. TAK1 mediates the prosurvival signal of the proinflammatory cytokines by inducing the nuclear localization of NF-kappaB and the activation of c-Jun N-terminal kinases (JNKs)/AP1 (11), whereas the proapoptotic signal is mediated by the activation of the caspase cascade (12). Studies have demonstrated that TAK1-transduced signals from TCRs and B cell receptors, as well as antigen stimulation, play a role in T and B cell activation and survival, T regulatory cell development, and B cell-mediated innate immunity (13-16). The role of TAK1 in hematopoiesis is still not fully understood. Although previous studies suggested that proinflammatory cytokines might play a negative role in hematopoiesis and contribute to some of the BM failure syndromes (17, 18), recent studies demonstrate that HSC/Ps are resistant to proinflammatory and stress signal-induced apoptosis (10, 19). We propose that TAK1 is expressed and activated in hematopoietic cells, including HSC/Ps, thus protecting them from apoptosis.
###end p 9
###begin p 10
###xml 66 68 66 68 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib11">11</xref>
###xml 70 72 70 72 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib13">13</xref>
###xml 259 263 259 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 318 322 318 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 273 277 <span type="species:ncbi:10090">mice</span>
###xml 332 336 <span type="species:ncbi:10090">mice</span>
The TAK1-null phenotype is lethal early in embryonic development (11, 13), impeding exploration of the role of TAK1 in adult hematopoiesis. To investigate whether TAK1 plays a role in the regulation of normal hematopoietic homeostasis, we generated inducible TAK1 knockout mice. We found that inducing the deletion of TAK1 in adult mice results in BM and liver failure due to massive cell-autonomous apoptotic death of hematopoietic cells, including HSC/Ps, and hepatocytes. Further study demonstrated that TAK1 mediates the survival signal in HSC/Ps via activation of JNK/AP1 and NF-kappaB signal pathways and up-regulation of survival gene expression.
###end p 10
###begin title 11
RESULTS
###end title 11
###begin title 12
TAK1 expression and activity in hematopoietic cells
###end title 12
###begin p 13
###xml 318 319 318 319 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 323 324 323 324 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 329 330 329 330 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 396 397 396 397 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 401 402 401 402 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 407 408 407 408 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 448 449 448 449 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 465 466 465 466 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 493 494 493 494 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 499 500 499 500 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 536 537 536 537 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 556 557 556 557 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 655 663 655 663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 I</xref>
###xml 803 804 803 804 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 844 845 844 845 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 888 889 888 889 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 899 910 899 910 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1, A&#8211;C</xref>
###xml 962 964 962 964 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib20">20</xref>
###xml 984 985 984 985 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1019 1020 1019 1020 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1043 1044 1043 1044 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1060 1071 1060 1071 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1, D&#8211;F</xref>
###xml 1290 1305 1290 1305 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1, G and H</xref>
###xml 1352 1353 1352 1353 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1422 1430 1422 1430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1 F</xref>
To study whether TAK1 is involved in normal hematopoiesis, we first examined whether TAK1 is expressed in hematopoietic cells by using quantitative RT-PCR assays. TAK1 knockout BM cells were used as a negative control. We found that TAK1 RNA is expressed in all lineages of hematopoietic cells, including HSCs (lineage-Sca1+c-kit+ cells [LSKs]), committed hematopoietic progenitors (CPs) (lineage-Sca1-c-kit+ cells [LKs]), mature myeloid cells (Gr1+), B cells (B220+), B cell progenitors (B220+c-kit+), nucleated erythroid cells (Ter119+), and T cells (CD3+). Its level of expression is also increased in progenitors including CPs and B cell progenitors (Fig. 1 I). Furthermore, by using a flow cytometry-based intracellular protein detection assay, we found that the expression of TAK1 protein in c-kit+ HSC/Ps (including HSCs and CPs) and Gr1+ myeloid cells was higher than that in B220+ B cells (Fig. 1, A-C); yet, TAK1 activity (indicated by p-TAK1 levels) (20) is higher in c-kit+ HSC/Ps than in differentiated Gr1+ myeloid cells and B220+ B lymphocytes (Fig. 1, D-F). We further separated HSCs and CPs by sca1 and c-kit staining followed by lineage depletion and found that, although TAK1 protein levels were comparable in HSCs and CPs, p-TAK1 levels were higher in CPs than in HSCs (Fig. 1, G and H). Interestingly, we also found that among B220+ cells, B cell progenitors displayed higher levels of TAK1 activity (Fig. 1 F).
###end p 13
###begin p 14
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 0 73 0 73 <bold xmlns:xlink="http://www.w3.org/1999/xlink"><italic>TAK1</italic> is expressed and activated in hematopoietic cells, including HSC/Ps.</bold>
###xml 535 536 535 536 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 564 565 564 565 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 607 608 607 608 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 685 686 685 686 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 722 723 722 723 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 728 729 728 729 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 802 806 802 806 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 912 916 912 916 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 1035 1039 1035 1039 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 1166 1167 1166 1167 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1187 1188 1187 1188 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1204 1205 1204 1205 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1239 1240 1239 1240 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1250 1254 1250 1254 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 1333 1334 1333 1334 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1339 1340 1339 1340 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1388 1392 1388 1392 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 1392 1395 1392 1395 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1465 1466 1465 1466 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1472 1473 1472 1473 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1482 1483 1482 1483 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 141 145 <span type="species:ncbi:10090">mice</span>
###xml 1049 1053 <span type="species:ncbi:10090">mice</span>
TAK1 is expressed and activated in hematopoietic cells, including HSC/Ps. BM cells were collected into lyse/fix buffer immediately after the mice were killed to fix the BM cells and lyse the RBCs simultaneously. BM-nucleated cells were washed three times with PBS containing 5% FBS to completely remove all traces of the lyse/fix buffer. The cells were stained with cell surface markers as indicated and then permeabilized using permeabilization buffer for TAK1 and p-TAK1 staining. (A-C) High level of TAK1 protein expression in c-kit+ hematopoietic cells and Gr1+ myeloid cells, but low expression in B220+ B cells. (D-F) TAK activity (shown here by p-TAK1 levels) is higher in c-kit+ hematopoietic cells (including B220+c-kit+ B cell progenitors, red arrow in F). (G and H) No obvious difference in TAK1 expression in LSK-HSC/Ps and LK-CPs, but increased TAK1 activity in LK-CPs compared with LSK-HSC/Ps. (I) TAK1 is expressed in all lineages of hematopoietic cells, including HSC/Ps, as shown by quantitative RT-PCR. BM cells from TAK1 knockout mice (4 d after mutation induction) were used as negative controls. Compared with differentiated cells, including Gr1+ myeloid cells, B220+ B cells, Ter119+-nucleated erythoid cells, and CD3+ T cells, TAK1 RNA expression was significantly higher in LK-CPs and B cell progenitors (B220+c-kit+). Both * and ** are P < 0.01. *, compared with TAK1-/- BM cells; **, compared with mature hematopoietic cells, including Gr1+, B220+, and CD3+ cells.
###end p 14
###begin title 15
###xml 28 31 28 31 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 32 36 <span type="species:ncbi:10090">mice</span>
Generation of inducible TAK1-/- mice
###end title 15
###begin p 16
###xml 76 80 76 80 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 96 102 96 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mx1Cre</italic>
###xml 102 103 102 103 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 107 112 107 112 <sup xmlns:xlink="http://www.w3.org/1999/xlink">fx/fx</sup>
###xml 103 112 103 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1<sup>fx/fx</sup></italic>
###xml 114 118 114 118 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 118 121 118 121 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 149 154 149 154 <sup xmlns:xlink="http://www.w3.org/1999/xlink">fx/fx</sup>
###xml 145 154 145 154 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1<sup>fx/fx</sup></italic>
###xml 165 171 165 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mx1Cre</italic>
###xml 201 205 201 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 299 304 299 304 <sup xmlns:xlink="http://www.w3.org/1999/xlink">fx/fx</sup>
###xml 295 304 295 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1<sup>fx/fx</sup></italic>
###xml 311 313 311 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib13">13</xref>
###xml 370 376 370 376 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mx1Cre</italic>
###xml 581 583 581 583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib21">21</xref>
###xml 745 747 745 747 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib21">21</xref>
###xml 781 785 781 785 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 785 788 785 788 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 804 810 804 810 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mx1Cre</italic>
###xml 810 811 810 811 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 811 815 811 815 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 815 818 815 818 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fx/</italic>
###xml 815 819 815 819 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>fx/</italic>+</sup>
###xml 821 825 821 825 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 825 828 825 828 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 862 868 862 868 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mx1Cre</italic>
###xml 868 869 868 869 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 873 878 873 878 <sup xmlns:xlink="http://www.w3.org/1999/xlink">fx/fx</sup>
###xml 869 878 869 878 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1<sup>fx/fx</sup></italic>
###xml 882 888 882 888 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mx1Cre</italic>
###xml 888 889 888 889 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 889 893 889 893 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 893 895 893 895 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fx</italic>
###xml 893 897 893 897 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>fx</italic>/+</sup>
###xml 955 959 955 959 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 959 962 959 962 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 986 990 986 990 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 990 993 990 993 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 998 1000 998 1000 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WT</italic>
###xml 1060 1064 1060 1064 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 1064 1067 1064 1067 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 1072 1074 1072 1074 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WT</italic>
###xml 1176 1180 1176 1180 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 90 94 <span type="species:ncbi:10090">mice</span>
###xml 155 159 <span type="species:ncbi:10090">mice</span>
###xml 172 176 <span type="species:ncbi:10090">mice</span>
###xml 305 309 <span type="species:ncbi:10090">mice</span>
###xml 377 381 <span type="species:ncbi:10090">mice</span>
###xml 414 419 <span type="species:ncbi:10090">mouse</span>
###xml 505 509 <span type="species:ncbi:10090">mice</span>
###xml 856 860 <span type="species:ncbi:10090">mice</span>
###xml 963 967 <span type="species:ncbi:10090">mice</span>
###xml 1044 1048 <span type="species:ncbi:10090">mice</span>
###xml 1293 1298 <span type="species:ncbi:10090">mouse</span>
###xml 1386 1390 <span type="species:ncbi:10090">mice</span>
To study whether TAK1 plays a role in hematopoiesis, we generated inducible TAK1 knockout mice (Mx1Cre+TAK1fx/fx, TAK1-/- hereafter) by crossing TAK1fx/fx mice with Mx1Cre mice. The second exon of the TAK1 gene (which encodes the enzyme's catalytic domain) is flanked with two loxp sites in the TAK1fx/fx mice (13) and thus can be deleted by Cre-mediated recombination. Mx1Cre mice are an interferon-inducible Cre mouse line in which Cre expression can be induced at any time after birth by injecting the mice with the interferon inducer polyinosinic:polycytidylic acid (polyI:C) (21). Mx1Cre-mediated recombination of loxp sites is very efficient in hematopoietic cells from the BM, spleen, and thymus, including HSC/Ps as well as liver cells (21). By proper mating, we generated TAK1-/-, heterozygous (Mx1Cre+TAK1fx/+, TAK1+/- hereafter), and WT control mice (Mx1Cre-TAK1fx/fx or Mx1Cre-TAK1fx/+, WT hereafter) in the same litter. Therefore, all of the TAK1-/- mice analyzed had both TAK1+/- and WT littermate controls. At 6-8 wk of age, the mice (including TAK1+/- and WT controls) were injected with polyI:C either once or three times (once every other day) to induce the TAK1 deletion. To control for the possibility that polyI:C injection itself might affect hematopoiesis, at least one mouse in each litter was maintained without injection and served as noninjected control. All mice were checked daily for phenotypic changes.
###end p 16
###begin title 17
###xml 41 45 <span type="species:ncbi:10090">mice</span>
Liver failure in inducible TAK1 knockout mice due to increased hepatocyte apoptosis
###end title 17
###begin p 18
###xml 22 26 22 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 26 29 26 29 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 164 168 164 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 168 171 168 171 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 268 272 268 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 272 275 272 275 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 312 320 312 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2 A</xref>
###xml 708 719 708 719 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2, B&#8211;E</xref>
###xml 963 967 963 967 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 967 970 967 970 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1025 1029 1025 1029 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 1029 1032 1029 1032 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1299 1303 1299 1303 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 1303 1306 1303 1306 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 30 34 <span type="species:ncbi:10090">mice</span>
###xml 172 176 <span type="species:ncbi:10090">mice</span>
###xml 237 241 <span type="species:ncbi:10090">mice</span>
###xml 276 280 <span type="species:ncbi:10090">mice</span>
###xml 350 354 <span type="species:ncbi:10090">mice</span>
###xml 744 748 <span type="species:ncbi:10090">mice</span>
###xml 971 975 <span type="species:ncbi:10090">mice</span>
###xml 1043 1047 <span type="species:ncbi:10090">mice</span>
###xml 1187 1191 <span type="species:ncbi:10090">mice</span>
###xml 1307 1311 <span type="species:ncbi:10090">mice</span>
We found that all the TAK1-/- mice died within 8-10 d after the first polyI:C injection, regardless of whether they were injected once or three times; however, the TAK1+/- mice showed no significant defects. By careful dissection of the mice, we found that all of the TAK1-/- mice had both jaundice and ascites (Fig. 2 A). The livers of the knockout mice were relatively smaller and stiff, and they appeared a pale, jaundiced color. Destruction of normal liver histological structure was evident upon microscopic analysis. The nuclei of >30-50% of the hepatocytes were condensed because of apoptosis, which was demonstrated by terminal deoxynucleotidyltransferase-mediated UTP end-labeling (TUNEL) staining (Fig. 2, B-E). Although, >30% of the mice showed intestinal, urinary bladder, and/or gallbladder hemorrhaging (not depicted), we believe that acute liver failure, as a consequence of massive hepatocyte apoptosis, was the major cause of mortality among the TAK1-/- mice. In support of this notion, we observed that the TAK1-/- recipient mice that received normal BM did not show any signs of bleeding but did show evidence of significant hepatocyte apoptosis (not depicted). These mice also died 8-10 d after their first polyI:C injection. This also suggests that the bleeding observed in the TAK1-/- mice was not due to the liver defects and was not the cause of mortality.
###end p 18
###begin p 19
###xml 42 46 42 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 46 49 46 49 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 0 55 0 55 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Hepatocyte apoptosis and liver failure in <italic>TAK1</italic><sup>&#8722;/&#8722;</sup> mice.</bold>
###xml 55 59 55 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 59 62 59 62 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 171 175 171 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 175 178 175 178 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 199 203 199 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 203 206 203 206 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 277 281 277 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 281 284 281 284 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 398 402 398 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 402 405 402 405 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 539 543 539 543 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 543 546 543 546 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 50 54 <span type="species:ncbi:10090">mice</span>
###xml 63 67 <span type="species:ncbi:10090">mice</span>
###xml 179 183 <span type="species:ncbi:10090">mice</span>
###xml 207 211 <span type="species:ncbi:10090">mice</span>
###xml 406 410 <span type="species:ncbi:10090">mice</span>
###xml 547 551 <span type="species:ncbi:10090">mice</span>
Hepatocyte apoptosis and liver failure in TAK1-/- mice.TAK1-/- mice were killed on day 8 after the first polyI:C injection. (A) Both jaundice and ascites were observed in TAK1-/- mice. Livers of the TAK1-/- mice were pale and jaundiced (left specimen, arrowhead) compared with TAK1+/- control (right specimen, arrow). Nuclear condensation due to apoptosis was observed in >30-50% of hepatocytes of TAK1-/- mice as shown by hematoxylin and eosin staining of liver sections (B), which is confirmed by TUNEL staining (D). Liver sections from TAK1+/- mice were used as controls. (C and E) Bars, 100 mum.
###end p 19
###begin title 20
###xml 28 32 <span type="species:ncbi:10090">mice</span>
BM failure in TAK1 knockout mice due to the apoptotic loss of hematopoietic cells
###end title 20
###begin p 21
###xml 23 27 23 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 287 291 287 291 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 291 294 291 294 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 301 316 301 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3, A and B</xref>
###xml 425 429 425 429 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 429 432 429 432 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 477 478 477 478 <sup xmlns:xlink="http://www.w3.org/1999/xlink">9</sup>
###xml 619 623 619 623 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 623 626 623 626 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 642 646 642 646 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 646 649 646 649 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 699 703 699 703 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 703 706 703 706 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 295 299 <span type="species:ncbi:10090">mice</span>
###xml 433 437 <span type="species:ncbi:10090">mice</span>
###xml 483 488 <span type="species:ncbi:9606">Human</span>
###xml 489 497 <span type="species:ncbi:9606">patients</span>
To investigate whether TAK1 deletion affects hematopoiesis, we first examined white blood cell (WBC) counts, platelet number (plt), RBC counts, and hemoglobin (Hb) concentrations at 8 d after the first polyI:C injection. We found that both WBCs and plt were significantly reduced in the TAK1-/- mice (Fig. 3, A and B). We believe that the decrease in plt counts was the reason for the bleeding seen in multiple organs in the TAK1-/- mice because their plt counts were <200 x 109/ml. Human patients showing such severe thrombocytopenia typically present with severe bleeding. However, RBCs and Hb were slightly lower in TAK1-/- than in WT and TAK1+/- controls (not depicted). These data suggest that TAK1-/- results in a pancytopenic effect.
###end p 21
###begin p 22
###xml 31 35 31 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 35 38 35 38 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 0 44 0 44 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Pancytopenia and BM failure in <italic>TAK1</italic><sup>&#8722;/&#8722;</sup> mice.</bold>
###xml 277 281 277 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 281 284 281 284 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 286 290 286 290 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 290 293 290 293 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 365 369 365 369 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 369 372 369 372 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 381 385 381 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 385 388 385 388 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 503 506 503 506 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 519 522 519 522 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 39 43 <span type="species:ncbi:10090">mice</span>
###xml 302 306 <span type="species:ncbi:10090">mice</span>
###xml 342 346 <span type="species:ncbi:10090">mice</span>
###xml 393 397 <span type="species:ncbi:10090">mice</span>
###xml 527 531 <span type="species:ncbi:10090">mice</span>
Pancytopenia and BM failure in TAK1-/- mice. Peripheral blood, BM, spleens, and thymuses were collected on day 8 after the first polyI:C injection. WBC count (A), plt in peripheral blood (B), and nucleated cell number in the BM (C), spleen (D), and thymus (E) were measured in TAK1-/-, TAK1+/-, and WT mice, as well as in noninjected control mice. BM sections from TAK1+/- (F) and TAK1-/- (G) mice at day 8 after the first polyI:C injection were stained with hematoxylin and eosin. BM sections from TAK1+/- (H) and TAK1-/- (I) mice at day 4 after the first polyI:C injection were stained with TUNEL to display the apoptotic cells (indicated by red color staining). Bars, 100 mum. *, P < 0.05; **, P < 0.01.
###end p 22
###begin p 23
###xml 37 41 37 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 41 44 41 44 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 131 135 131 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 135 138 135 138 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 364 368 364 368 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 368 371 368 371 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 391 395 391 395 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 395 398 395 398 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 457 468 457 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3, C&#8211;E</xref>
###xml 730 734 730 734 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 734 737 734 737 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 835 839 835 839 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 1005 1009 1005 1009 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 1009 1012 1009 1012 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1158 1162 1158 1162 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 1162 1165 1162 1165 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 1357 1361 1357 1361 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 1361 1364 1361 1364 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1656 1660 1656 1660 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 1660 1663 1660 1663 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1745 1749 1745 1749 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 1749 1752 1749 1752 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1787 1788 1787 1788 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 1822 1826 1822 1826 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 1826 1829 1826 1829 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 45 49 <span type="species:ncbi:10090">mice</span>
###xml 151 155 <span type="species:ncbi:10090">mice</span>
###xml 372 376 <span type="species:ncbi:10090">mice</span>
###xml 414 418 <span type="species:ncbi:10090">mice</span>
###xml 451 455 <span type="species:ncbi:10090">mice</span>
###xml 613 618 <span type="species:ncbi:10090">mouse</span>
###xml 622 627 <span type="species:ncbi:10090">mouse</span>
###xml 796 800 <span type="species:ncbi:10090">mice</span>
###xml 885 889 <span type="species:ncbi:10090">mice</span>
###xml 1013 1017 <span type="species:ncbi:10090">mice</span>
###xml 1195 1199 <span type="species:ncbi:10090">mice</span>
###xml 1365 1369 <span type="species:ncbi:10090">mice</span>
###xml 1664 1668 <span type="species:ncbi:10090">mice</span>
###xml 1753 1757 <span type="species:ncbi:10090">mice</span>
###xml 1830 1835 <span type="species:ncbi:10090">mouse</span>
###xml 1917 1922 <span type="species:ncbi:10090">mouse</span>
To study whether the pancytopenia in TAK1-/- mice was due to BM hematopoietic defects, we collected BM, spleens, and thymuses from TAK1-/- and control mice at day 8 after the first polyI:C injection. The total nucleated cell number (TNC) of BM, spleens, and thymuses were analyzed. We found that the TNC of BM, spleens, and thymuses was significantly decreased in TAK1-/- mice compared with TAK1+/- and WT control mice, as well as noninjected control mice (Fig. 3, C-E, and Fig. S1, which is available at ). Although the TNCs in the BM, spleens, and thymuses in the polyI:C-injected groups were more diverse from mouse to mouse, shown by the relatively larger standard deviations, no significant differences were observed between TAK1+/-and WT, the latter being comparable to noninjected control mice. This indicates that heterozygous TAK1 deletion did not affect hematopoiesis in the mice. It also suggests that polyI:C injection itself likely contributes negligibly to the phenotypes we observed in the TAK1-/- mice. This notion was supported by cell surface staining and flow cytometric analysis. We found that there were no significant differences among TAK1+/-, WT, and noninjected control mice in the percentage of myeloid cells and T and B lymphocytes in all hematopoietic tissues examined including the peripheral blood, BM, and spleen. However, in TAK1-/- mice, significant increases in T cell percentage were consistently observed in the peripheral blood, BM, and spleen (the absolute T cell number in all these tissues was still dramatically lower than controls; Fig. S2, available at ). We believe that the increase in T cell percentage in the TAK1-/- mice has nothing to do with thymic T cell production because the thymus gland in TAK1-/- mice was very small. Only 1-4 x 106 TNCs could be obtained from each TAK1-/- mouse thymus, which was 1/20 to 1/100 of the number of TNCs obtained from each control mouse thymus.
###end p 23
###begin p 24
###xml 44 48 44 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 48 51 48 51 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 204 219 204 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3, E and G</xref>
###xml 250 254 250 254 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 254 257 254 257 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 342 346 342 346 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 346 349 346 349 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 418 426 418 426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3 I</xref>
###xml 52 56 <span type="species:ncbi:10090">mice</span>
###xml 154 158 <span type="species:ncbi:10090">mice</span>
###xml 258 262 <span type="species:ncbi:10090">mice</span>
###xml 350 354 <span type="species:ncbi:10090">mice</span>
Histological sectioning showed that BM from TAK1-/- mice was hypocellular and BM structure was destroyed, similar to the myelodepletion phenotype seen in mice after high-dose chemotherapy or irradiation (Fig. 3, E and G). These data suggest that the TAK1-/- mice had BM failure. In situ TUNEL staining demonstrated that the BM failure of the TAK1-/- mice was due to the massive apoptotic death of hematopoietic cells (Fig. 3 I).
###end p 24
###begin p 25
###xml 55 58 55 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK</italic>
###xml 58 61 58 61 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 90 94 90 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 94 97 94 97 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 104 108 104 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 108 111 108 111 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 173 177 173 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 177 180 177 180 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 240 244 240 244 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 244 247 244 247 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 69 73 <span type="species:ncbi:10090">mice</span>
###xml 98 102 <span type="species:ncbi:10090">mice</span>
###xml 112 116 <span type="species:ncbi:10090">mice</span>
###xml 181 185 <span type="species:ncbi:10090">mice</span>
###xml 216 220 <span type="species:ncbi:10090">mice</span>
###xml 248 252 <span type="species:ncbi:10090">mice</span>
Because no significant difference was observed between TAK+/- and WT mice, and similar to TAK1-/- mice, TAK1+/- mice also express Cre after polyI:C injection, we considered TAK1+/- mice to be better controls than WT mice. Therefore we used TAK1+/- mice as controls in most of our subsequent studies.
###end p 25
###begin title 26
###xml 94 97 94 97 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 98 102 <span type="species:ncbi:10090">mice</span>
HSC/Ps are among those hematopoietic cells affected by TAK1 deletion-induced apoptosis in TAK1-/- mice
###end title 26
###begin p 27
###xml 47 51 47 51 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 51 54 51 54 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 224 228 224 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 228 231 228 231 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 238 249 238 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4, A&#8211;D</xref>
###xml 360 368 360 368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 B</xref>
###xml 453 457 453 457 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 457 460 457 460 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 494 502 494 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 E</xref>
###xml 645 649 645 649 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 649 652 649 652 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 776 777 776 777 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 791 792 791 792 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 838 842 838 842 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 842 845 842 845 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 986 987 986 987 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1081 1089 1081 1089 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4 F</xref>
###xml 55 59 <span type="species:ncbi:10090">mice</span>
###xml 232 236 <span type="species:ncbi:10090">mice</span>
###xml 461 465 <span type="species:ncbi:10090">mice</span>
###xml 846 850 <span type="species:ncbi:10090">mice</span>
###xml 873 877 <span type="species:ncbi:10090">mice</span>
###xml 1135 1139 <span type="species:ncbi:10090">mice</span>
To investigate whether HSC/Ps were affected in TAK1-/- mice, we first examined HSC/P numbers by cell surface marker staining and flow cytometric analysis. We found that both LSK-HSCs and LK-CPs were significantly reduced in TAK1-/- mice (Fig. 4, A-D). The obvious reduction in HSCs and CPs could be observed at day 4 after the first dose of polyI:C injection (Fig. 4 B). There were almost no HSCs nor CPs detectable at day 8. The reduction in HSC/Ps in TAK1-/- mice was confirmed by CFU assay (Fig. 4 E). We found that the CFU number (counted at day 12 after seeding, which reflects the number of functional HSC/Ps) was significantly reduced in TAK1-/- BM. Upon further analysis using annexin V staining, we found a three- to fivefold increase in apoptosis (shown as annexin V+) in the c-kit+ population (consisting of HSCs and CPs) from TAK1-/- mice compared with control mice at 16 h after a single polyI:C injection. Upon further analysis by separating HSCs from CPs within the c-kit+ population, we found apoptosis among both of these cell types to be significantly increased (Fig. 4 F) compared with such cells taken from control mice.
###end p 27
###begin p 28
###xml 23 27 23 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 69 73 69 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 73 76 73 76 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 0 82 0 82 <bold xmlns:xlink="http://www.w3.org/1999/xlink">HSC/Ps are affected by <italic>TAK1</italic> deletion&#8211;induced apoptotic cell death in <italic>TAK1</italic><sup>&#8722;/&#8722;</sup> mice.</bold>
###xml 105 109 105 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 109 112 109 112 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 117 121 117 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 121 124 121 124 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 349 353 349 353 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 353 356 353 356 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 430 434 430 434 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 434 437 434 437 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 530 534 530 534 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 534 537 534 537 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 553 557 553 557 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 601 605 601 605 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 605 608 605 608 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 613 617 613 617 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 617 620 617 620 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 77 81 <span type="species:ncbi:10090">mice</span>
###xml 125 129 <span type="species:ncbi:10090">mice</span>
###xml 357 362 <span type="species:ncbi:10090">mouse</span>
###xml 621 625 <span type="species:ncbi:10090">mice</span>
HSC/Ps are affected by TAK1 deletion-induced apoptotic cell death in TAK1-/- mice. BM was collected from TAK1+/- and TAK1-/- mice on days 4, 6, and 8 after the first polyI:C injection. After lysis of RBCs, BM-nucleated cells were stained with cell surface markers and analyzed by flow cytometry for HSCs and CPs. Progressive loss of HSCs and CPs in TAK1-/- mouse BM is shown by lineage marker and Sca1 c-kit staining (B-D). Day 8 TAK1+/- BM cells were used as a control (A). (E) Progressive reduction of colony-forming ability of TAK1-/- BM cells after TAK1 deletion. (F) BM cells were collected from TAK1-/- and TAK1+/- mice 16 h after a single polyI:C injection, and apoptosis was checked by annexin V staining. *, P < 0.05; **, P < 0.01.
###end p 28
###begin title 29
###xml 27 30 27 30 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 31 35 <span type="species:ncbi:10090">mice</span>
Hematopoietic cells of TAK1-/- mice show intrinsic defects
###end title 29
###begin p 30
###xml 108 110 108 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib22">22</xref>
###xml 170 174 170 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 174 177 174 177 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 275 279 275 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 279 282 279 282 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 466 470 466 470 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 470 473 470 473 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 795 799 795 799 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 799 802 799 802 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 820 824 820 824 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 824 827 824 827 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 855 876 855 876 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5, A, B, and E&#8211;H</xref>
###xml 927 931 927 931 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 931 934 931 934 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1096 1100 1096 1100 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 1100 1103 1100 1103 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1412 1416 1412 1416 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 1416 1419 1416 1419 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1487 1491 1487 1491 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 1491 1494 1491 1494 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1525 1529 1525 1529 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 1612 1627 1612 1627 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5, C and D</xref>
###xml 1718 1722 1718 1722 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 1722 1725 1722 1725 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1769 1773 1769 1773 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 1773 1776 1773 1776 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 1789 1800 1789 1800 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5, E&#8211;H</xref>
###xml 1848 1852 1848 1852 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 1852 1855 1852 1855 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 2054 2058 2054 2058 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 2058 2061 2058 2061 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 2091 2095 2091 2095 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 2095 2098 2095 2098 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 2111 2119 2111 2119 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5 E</xref>
###xml 2257 2261 2257 2261 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 2261 2264 2261 2264 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 178 182 <span type="species:ncbi:10090">mice</span>
###xml 389 393 <span type="species:ncbi:10090">mice</span>
###xml 935 939 <span type="species:ncbi:10090">mice</span>
###xml 1062 1066 <span type="species:ncbi:10090">mice</span>
Previously, we have found that Mx1Cre can mediate gene deletion in both hematopoietic and BM stromal cells (22). To address whether the defects of hematopoietic cells in TAK1-/- mice were intrinsic to the cells, reciprocal BM transplantations were performed. We transplanted TAK1-/- BM cells (before deletion was induced) into lethally irradiated syngeneic WT recipients. Because in these mice the BM microenvironment is normal, we were able to test the function of TAK1-/- hematopoietic cells within this normal BM microenvironment. 1 mo after transplantation, the recipients received polyI:C injections every other day for a total of three injections and were killed for analysis on day 8 after the first injection. We found pancytopenia and BM failure in the recipients that had received the TAK1-/- BM; however, the TAK1+/- BM recipients were normal (Fig. 5, A, B, and E-H). This suggests that the hematopoietic cells from TAK1-/- mice have cell-intrinsic defects that prohibit their survival in a normal BM microenvironment. We also transplanted BM from WT mice into the lethally irradiated TAK1-/- recipients (before deletion induction). 1 mo after transplantation, the recipients were given three polyI:C injections, once every other day, and the livers, peripheral blood, spleens, and BM were harvested for analysis on day 8 after the last injection. We found significant apoptosis of hepatocytes in all TAK1-/- recipients (not depicted). However, the normal BM hematopoiesis in TAK1-/- recipients suggested that the TAK1 deletion BM microenvironment has a normalizing hematopoietic supportive function (Fig. 5, C and D). Consistent with this observation, we found that plt counts and Hb concentrations in the TAK1-/- recipients were comparable to those of the TAK1+/- recipients (Fig. 5, E-H). Furthermore, we found that the livers of the TAK1-/- recipients that had received WT BM had obvious myeloid cell infiltration (not depicted). The WBC counts, neutrophil percentages, and neutrophil/lymphocyte ratios were significantly increased in the TAK1-/- recipients compared with the TAK1+/- recipients (Fig. 5 E and not depicted). We believe that the increase in WBC counts and neutrophils as well as the myeloid infiltration of liver tissue in the TAK1-/- recipients were due to inflammatory reactions induced by hepatocyte apoptosis.
###end p 30
###begin p 31
###xml 27 31 27 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 31 34 31 34 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 0 42 0 42 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Cell-autonomous defects of <italic>TAK1</italic><sup>&#8722;/&#8722;</sup> HSC/Ps.</bold>
###xml 112 116 112 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 116 119 116 119 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 240 244 240 244 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 244 247 244 247 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 287 291 287 291 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 434 438 434 438 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 438 441 438 441 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 639 643 639 643 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 643 646 643 646 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 711 715 711 715 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 715 718 715 718 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 931 935 931 935 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 935 938 935 938 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 981 985 981 985 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 985 988 985 988 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1048 1052 1048 1052 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 1052 1055 1052 1055 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1072 1073 1072 1073 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1130 1131 1130 1131 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1194 1195 1194 1195 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1237 1241 1237 1241 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 1357 1361 1357 1361 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 1361 1364 1361 1364 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 1442 1446 1442 1446 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 1446 1449 1446 1449 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1515 1516 1515 1516 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 181 185 <span type="species:ncbi:10090">mice</span>
###xml 248 252 <span type="species:ncbi:10090">mice</span>
###xml 367 371 <span type="species:ncbi:10090">mice</span>
###xml 442 446 <span type="species:ncbi:10090">mice</span>
###xml 564 568 <span type="species:ncbi:10090">mice</span>
###xml 1290 1294 <span type="species:ncbi:10090">mice</span>
###xml 1494 1498 <span type="species:ncbi:10090">mice</span>
Cell-autonomous defects of TAK1-/- HSC/Ps. Reciprocal transplantation assay was performed by transplantation of TAK1-/- BM (before mutation was induced) into lethally irradiated WT mice (A) and, reciprocally, WT BM into lethally irradiated TAK1-/- mice (before mutation was induced; C). TAK1 deletion was induced 1 mo after transplantation by injecting the recipient mice with polyI:C every other day for a total of three injections. TAK1+/- mice were used as respective controls in this experiment (B and D). On day 8 after the first polyI:C injection, recipient mice were killed for analysis. BM sections from the recipients showed that TAK1-/- HSC/Ps failed to grow in the WT BM environment (A), whereas the TAK1-/- BM microenvironment was able to support the growth of WT HSC/Ps (C). (E-H) Significant reduction of WBC counts and plt in peripheral blood, and nucleated cells in the BM and spleen in WT recipients that received TAK1-/- BM. (E) Obvious increase in WBC counts in TAK1-/- recipients that received WT BM. (I and J) Equal numbers of TAK1-/- BM cells (CD45.2+, before mutation was induced) were mixed with WT (CD45.1+) BM cells and transplanted into lethally irradiated WT (CD45.1+) recipients. 6 wk after transplantation, TAK1 mutation was induced by injecting the recipient mice with polyI:C every other day for a total of three injections. TAK1+/- BM cells were transplanted in parallel as a control. The contribution of the TAK1-/- BM HSC/Ps to hematopoiesis in the recipient mice (shown as CD45.2+ percentage in peripheral blood) was significantly lower than that of control BM HSC/Ps. Data shown in I and J were analyzed on day 15 after the first polyI:C injection. *, P < 0.05; **, P < 0.01.
###end p 31
###begin title 32
DISCUSSION
###end title 32
###begin p 33
###xml 96 98 93 95 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib23">23</xref>
###xml 171 173 168 170 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib13">13</xref>
###xml 176 180 173 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 372 376 366 370 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 453 455 444 446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib24">24</xref>
###xml 599 601 590 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib11">11</xref>
###xml 186 190 <span type="species:ncbi:10090">mice</span>
###xml 271 276 <span type="species:ncbi:10090">mouse</span>
TAK1 was originally identified as a key regulator of TGF-beta/bone morphogenic protein signals (23). It is known to play an important role in early embryonic development (13). TAK1-null mice die at embryonic day 11.5 with significant vascular defects, reminiscent of the mouse phenotype in which the TGF-beta1 receptors ALK-1 and endoglin have been knocked out. Moreover, TAK1 overexpression can compensate for the TGFbeta1 receptor knockout phenotype (24). However, in vitro biochemical and in vivo genetic studies suggest that TAK1 is also a significant mediator of inflammatory cytokine signals (11).
###end p 33
###begin p 34
###xml 33 37 33 37 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 225 227 217 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib11">11</xref>
###xml 316 320 308 312 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 420 422 404 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib25">25</xref>
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
###xml 43 47 <span type="species:ncbi:10090">mice</span>
Mouse embryonic fibroblasts from TAK1-null mice exhibit dramatically impaired NF-kappaB and JNK activation through TNFR-1, IL-1R, and Toll-like receptors. These cells are also highly sensitive to TNF-alpha-induced apoptosis (11). TAK1 has also been found to be critical for keratinocyte survival. Keratinocytes with TAK1 deletions are inactivated for NF-kappaB and JNK, and are sensitive to TNF-alpha-induced apoptosis (25).
###end p 34
###begin p 35
###xml 146 150 146 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 347 351 347 351 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 199 203 <span type="species:ncbi:10090">mice</span>
Our data suggest that TAK1 might mediate a general survival signal for many tissue cells, although the sensitivity of different types of cells to TAK1 deletion varies. In our inducible TAK1 knockout mice, massive apoptotic cell death was observed in hematopoietic cells in the BM, spleen, and thymus, as well as in hepatocytes, where Cre-mediated TAK1 deletion occurred. We also found that in hematopoietic cells and hepatocytes, TAK1 stimulated a survival signal also mediated by up-regulating the expression of survival genes via the IKKkappa-NF-kappaB and JNK-AP1 signaling pathways (not depicted).
###end p 35
###begin p 36
###xml 510 512 490 492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib26">26</xref>
###xml 557 561 537 541 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 561 564 541 544 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 728 730 700 702 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib26">26</xref>
###xml 789 793 761 765 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 793 796 765 768 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 1006 1008 970 972 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib27">27</xref>
###xml 1217 1219 1173 1175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib27">27</xref>
###xml 284 288 <span type="species:ncbi:10090">mice</span>
###xml 565 569 <span type="species:ncbi:10090">mice</span>
###xml 666 670 <span type="species:ncbi:10090">mice</span>
###xml 694 698 <span type="species:ncbi:10090">mice</span>
###xml 797 801 <span type="species:ncbi:10090">mice</span>
###xml 857 861 <span type="species:ncbi:10090">mice</span>
###xml 1063 1067 <span type="species:ncbi:10090">mice</span>
It has been reported that NF-kappaB mediates a very important survival signal to protect cells from TNF-alpha-induced apoptosis. Inactivation of NF-kappaB by gene mutation or pharmacological inhibition sensitizes such cells to TNF-alpha-induced apoptosis. However, NF-kappaB knockout mice (Mx1Cre-mediated polyI:C-inducible knockout, the same system we used in our present studies) developed normally under normal husbandry without differences in gross anatomy, histological organization, or hepatic function (26). In contrast to the acute liver failure of TAK1-/- mice, the syndrome of hepatic failure resulting from hepatocyte apoptosis seen in NF-kappaB knockout mice occurred only when the mice were treated with TNF-alpha (26). Moreover, as opposed to the BM failure phenotype of our TAK1-/- mice, which was secondary to cell-autonomous apoptosis, the mice with IKKalpha/NF-kappaB signal inactivation showed stress-related B and T cell depletion, whereas HSC/Ps remained unaffected in this condition (27). In fact, the myeloid cells of NF-kappaB-inactivated mice show a high proliferative index and multiple tissue inflammation reactions due to autocrine secretion of inflammatory cytokines (such as TNF-alpha) (27). This suggests that IKKbeta/NF-kappaB signaling is not essential for the survival of HSC/Ps and myeloid cells.
###end p 36
###begin p 37
###xml 3 7 3 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 7 10 7 10 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 238 240 234 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib28">28</xref>
###xml 379 383 <span type="species:ncbi:10090">mice</span>
###xml 453 458 <span type="species:ncbi:10090">mouse</span>
In TAK1-/- HSC/Ps, in addition to the inactivation of NF-kappaB signals, JNK signals were also inactivated. The role of JNK signaling is cell context dependent. Both proapoptotic and prosurvival effects of JNK signals have been reported (28). The role of JNK in HSC/Ps has not yet been addressed. We predict that both JNK and NF-kappaB signals are required for HSC/P survival in mice. This needs to be further confirmed by conditional compound knockout mouse studies.
###end p 37
###begin p 38
###xml 30 34 30 34 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 308 310 308 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib13">13</xref>
###xml 311 313 311 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib16">16</xref>
###xml 460 462 460 462 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib13">13</xref>
###xml 463 465 463 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib16">16</xref>
###xml 485 489 485 489 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 489 492 489 492 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 746 752 746 752 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3</xref>
###xml 778 779 778 779 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1183 1187 1183 1187 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 44 48 <span type="species:ncbi:10090">mice</span>
###xml 343 347 <span type="species:ncbi:10090">mice</span>
###xml 493 497 <span type="species:ncbi:10090">mice</span>
###xml 922 926 <span type="species:ncbi:10090">mice</span>
Studies using tissue-specific TAK1 knockout mice have demonstrated that TAK1, mediating B cell receptor signaling and antigen responses in B cells and TCR signaling in T cells, is essential for B cell-mediated innate immunity and both peripheral T cell and T-regular cell activation, survival, and function (13-16). However, in these knockout mice, significant reductions of nucleated cells in the thymus and of B cells in the BM and spleen were not observed (13-16). In our inducible TAK1-/- mice, we found significant reductions in the numbers of all lineages of hematopoietic cells, including myeloid cells and B cells and T cells in the spleen and BM. We also found a dramatic reduction in thymus size due to decreased numbers of thymocytes (Fig. 3). We speculate that c-kit+ progenitors might possibly rely more on TAK1 for their survival, and that these were not targeted in the B cell- and T cell-specific knockout mice. In support of this idea, our data showed higher TAK1 activity in HSC/Ps and B cell progenitors than mature myeloid and B cells. But further study will be needed to establish this definitively. Whether cells with higher TAK1 activity are more sensitive to TAK1 deletion-induced apoptosis than cells with lower TAK1 activity will require further detailed investigation.
###end p 38
###begin p 39
###xml 110 112 106 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib29">29</xref>
###xml 114 116 110 112 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib30">30</xref>
###xml 299 303 291 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 303 306 295 298 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 412 416 404 408 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 307 311 <span type="species:ncbi:10090">mice</span>
Both JNK and NF-kappaB have been found to be activated in many malignant disorders and inflammatory diseases (29, 30). We predict that TAK1, which is upstream of JNK and NF-kappaB, might also be involved in these disorders. Further study may also reveal whether the BM failure phenotype seen in our TAK1-/- mice might also be involved in some BM failure syndromes such as aplastic anemia. Further examination of TAK1 expression profiles and activities in clinical samples could be expected to provide new insights into the important roles TAK1 might play in these diseases.
###end p 39
###begin title 40
MATERIALS AND METHODS
###end title 40
###begin title 41
###xml 24 28 24 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 39 43 39 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 43 46 43 46 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 48 52 <span type="species:ncbi:10090">mice</span>
Generation of inducible TAK1 knockout (TAK1-/-) mice.
###end title 41
###begin p 42
###xml 4 9 4 9 <sup xmlns:xlink="http://www.w3.org/1999/xlink">fx/fx</sup>
###xml 0 9 0 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1<sup>fx/fx</sup></italic>
###xml 42 44 42 44 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib13">13</xref>
###xml 61 65 61 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 102 108 102 108 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mx1Cre</italic>
###xml 152 154 152 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib21">21</xref>
###xml 544 550 544 550 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mx1Cre</italic>
###xml 565 570 565 570 <sup xmlns:xlink="http://www.w3.org/1999/xlink">fx/fx</sup>
###xml 561 570 561 570 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1<sup>fx/fx</sup></italic>
###xml 633 637 633 637 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 663 667 663 667 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 667 670 667 670 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 672 676 672 676 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 676 679 676 679 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 695 701 695 701 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Mx1Cre</italic>
###xml 701 702 701 702 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 702 706 702 706 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 706 708 706 708 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fx</italic>
###xml 706 710 706 710 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>fx</italic>/+</sup>
###xml 724 730 724 730 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MX1Cre</italic>
###xml 730 731 730 731 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 735 740 735 740 <sup xmlns:xlink="http://www.w3.org/1999/xlink">fx/fx</sup>
###xml 731 740 731 740 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1<sup>fx/fx</sup></italic>
###xml 744 750 744 750 <italic xmlns:xlink="http://www.w3.org/1999/xlink">MX1Cre</italic>
###xml 750 751 750 751 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;</sup>
###xml 751 755 751 755 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 755 757 755 757 <italic xmlns:xlink="http://www.w3.org/1999/xlink">fx</italic>
###xml 755 759 755 759 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>fx</italic>/+</sup>
###xml 805 809 805 809 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 809 812 809 812 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 982 986 982 986 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 986 989 986 989 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 1148 1152 1147 1151 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 10 14 <span type="species:ncbi:10090">mice</span>
###xml 109 113 <span type="species:ncbi:10090">mice</span>
###xml 161 165 <span type="species:ncbi:10090">mice</span>
###xml 551 555 <span type="species:ncbi:10090">mice</span>
###xml 571 575 <span type="species:ncbi:10090">mice</span>
###xml 647 651 <span type="species:ncbi:10090">mice</span>
###xml 813 817 <span type="species:ncbi:10090">mice</span>
###xml 872 877 <span type="species:ncbi:10090">mouse</span>
###xml 966 970 <span type="species:ncbi:10090">mice</span>
TAK1fx/fx mice were described previously (13). Exon-2 of the TAK1 gene was flanked by two loxp sites. Mx1Cre mice were purchased from JAX Laboratories (21). All mice were maintained according to the standards set forth in the National Institutes of Health Guidelines for the Care and Use of Animals in the animal facility at Loyola University Medical Center in a CD57B6 background. All experiments performed on animals were approved in advance by Loyola University Institutional Animal Care and Use Committee (protocol no. 108832). By crossing Mx1Cre mice with TAK1fx/fx mice and then backcrossing, we generated interferon-inducible TAK1 knockout mice, including TAK1-/-, TAK1+/- (heterozygous, Mx1Cre+TAK1fx/+) and WT (WT, MX1Cre-TAK1fx/fx or MX1Cre-TAK1fx/+) animals in the same litter, so that all the TAK1-/- mice analyzed had proper controls. 6-8 wk after birth, one mouse from each litter was maintained without injection as noninjected control, and all other mice, including TAK1+/- and WT controls, were injected with 5 mug/g body weight of polyI:C for either a single injection or every other day for a total of three injections to induce TAK1 deletions.
###end p 42
###begin title 43
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse hematopoietic phenotype analysis.
###end title 43
###begin p 44
###xml 444 446 444 446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="bib22">22</xref>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice were killed at the indicated time points to collect peripheral blood, spleen, thymus, and BM. Peripheral blood was analyzed for WBC counts, plt, RBC counts, and Hb concentration by using Hemavet 950FS (Drew Scientific Inc.). After lysis of RBCs, nucleated cells from peripheral blood, spleen, thymus, and BM were counted and further stained with cell surface markers for phenotype analysis by using flow cytometry as described previously (22). All the fluorescent antibodies used in flow cytometric analysis were purchased from eBioscience.
###end p 44
###begin title 45
Reciprocal BM transplantation.
###end title 45
###begin p 46
###xml 51 55 51 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 55 58 55 58 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 62 66 62 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 66 69 66 69 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 96 100 96 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 198 199 198 199 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 541 545 541 545 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 545 548 545 548 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 553 557 553 557 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 557 560 557 560 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 619 623 619 623 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 70 74 <span type="species:ncbi:10090">mice</span>
###xml 156 160 <span type="species:ncbi:10090">mice</span>
###xml 177 182 <span type="species:ncbi:10090">mouse</span>
###xml 494 498 <span type="species:ncbi:10090">mice</span>
###xml 571 575 <span type="species:ncbi:10090">mice</span>
To test the role of TAK1 in HSC/Ps, BM from either TAK1-/- or TAK1+/- mice (before induction of TAK1 deletion) was transplanted into lethally irradiated WT mice. Each recipient mouse received 5 x 106 nucleated BM cells. 6 wk after transplantation, the recipients were injected with polyI:C every other day for a total of three injections. Hematopoietic phenotypes were analyzed on day 8 after the first injection. To test the role of TAK1 on the function of the BM microenvironment, BM from WT mice was transplanted into lethally irradiated TAK1-/- and TAK1+/- recipient mice (before mutation was induced). 6 wk later, TAK1 deletion was induced by three polyI:C injections. Both liver and hematopoietic phenotypes were analyzed on day 8 after the first injection.
###end p 46
###begin title 47
Competitive BM transplantation.
###end title 47
###begin p 48
###xml 17 21 17 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 21 24 21 24 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 32 33 32 33 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 55 59 55 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 84 85 84 85 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 165 166 165 166 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 192 196 192 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 196 199 196 199 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 371 372 371 372 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 446 450 446 450 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 450 453 450 453 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 458 462 458 462 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 462 465 462 465 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 540 544 540 544 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 544 547 544 547 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 603 607 589 593 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 607 610 593 596 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
###xml 764 768 736 740 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 768 771 740 743 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 87 92 <span type="species:ncbi:10090">mouse</span>
###xml 178 182 <span type="species:ncbi:10090">mice</span>
###xml 200 204 <span type="species:ncbi:10090">mice</span>
###xml 809 813 <span type="species:ncbi:10090">mice</span>
Equal numbers of TAK1-/- (CD45.2+, before induction of TAK1 deletion) and WT (CD45.1+) mouse BM cells were mixed and transplanted into lethally irradiated WT (CD45.1+) recipient mice. Control TAK1+/- mice were transplanted in the same manner. 6 wk after transplantation, the contribution of donor HSC/Ps to hematopoiesis in recipients was assessed by analyzing the CD45.2+ cell percentage in the peripheral blood of recipients. As expected, both TAK1-/- and TAK1+/- HSC/Ps contributed close to 50% of hematopoietic cells in the recipients (TAK1-/- HSC/Ps contribute approximately46.8% +/- 5.6%, whereas TAK1+/- HSC/Ps contribute approximately51.6% +/- 6.1%). Recipients were next injected with three polyI:C injections as described above, and the contributions of TAK1-/- HSC/Ps to hematopoiesis in recipient mice were evaluated again on day 15 after the first injection.
###end p 48
###begin title 49
Apoptosis analysis.
###end title 49
###begin p 50
###xml 115 116 115 116 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 303 307 303 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 307 310 307 310 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 622 623 622 623 <sup xmlns:xlink="http://www.w3.org/1999/xlink">6</sup>
###xml 844 845 843 844 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 1062 1063 1061 1062 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+</sup>
###xml 323 327 <span type="species:ncbi:10090">mice</span>
Hepatocyte apoptosis was analyzed by counting the percentage of hepatocytes with small, condensed nuclear and TUNEL+ staining. TUNEL staining was performed using the DeadEnd Colorimetric TUNEL System (Promega) according to the protocol supplied. To analyze apoptosis in BM HSC/Ps, BM was collected from TAK1-/- and control mice at 15-18 h after a single polyI:C injection. BM cells were collected into lyse/fix buffer (BD Biosciences) for not more than 10 min to fix the nucleated cells and lyse the RBCs simultaneously. After two washes with cold PBS/2% FBS, the nucleated cells were adjusted to a concentration of 5 x 106/ml in 1x Binding Buffer (BD Biosciences) and aliquotted into 5-ml staining tubes, 100 mul of cells per tube. Cells were then stained with allophycocyanin (APC)-c-kit and FITC-annexin V (BD Biosciences) or PECy5.5-lineage+ markers (including Gr1, B220, Ter119, CD3, and CD8), PE-Sca1, APC-c-kit, and FITC-annexin V for 20 min at room temperature. After two washes with 1x Binding Buffer, cells were analyzed by flow cytometry for annexin V+ cell percentage in different cell populations.
###end p 50
###begin title 51
Intracellular protein analysis.
###end title 51
###begin p 52
###xml 653 659 <span type="species:ncbi:9986">Rabbit</span>
###xml 671 677 <span type="species:ncbi:9986">rabbit</span>
###xml 691 697 <span type="species:ncbi:9986">rabbit</span>
###xml 720 726 <span type="species:ncbi:9986">rabbit</span>
###xml 759 765 <span type="species:ncbi:9986">rabbit</span>
BM cells were collected into lyse/fix buffer (BD Biosciences) to simultaneously fix the nucleated cells and lyse the RBCs. After two washes with cold PBS/2% FBS, BM cells were stained with cell surface markers as indicated for 30 min. Cells were then permeabilized using a fixation/permeabilization kit (BD Biosciences) for 20 min at room temperature. Cells were then washed with wash buffer twice and stained with antibodies against intracellular proteins, followed by APC-conjugated secondary antibody staining. The levels of intracellular proteins were detected by flow cytometry comparing the APC intensity in different populations of the BM cells. Rabbit anti-TAK1, rabbit anti-p-TAK1, rabbit anti-p-NF-kappaB P65, rabbit anti-p-P38 (Thr180/Tyr182), and rabbit p-JNK (Thr183/Tyr185) antibodies were purchased from Cell Signaling Technology.
###end p 52
###begin title 53
RT-PCR to detect gene expression.
###end title 53
###begin p 54
###xml 268 272 <span type="species:ncbi:10090">mice</span>
RNA was extracted using RNeasy Plus Mini kit (QIAGEN). cDNA was prepared using SuperScript First-Strand Synthesis System (Invitrogen). Quantitative PCR was performed by using SYBR Green PCR master (Applied Biosystems). Each sample was a mixture of LSK-HSCs from three mice with the same phenotype. Triplicate RT-PCRs were performed.
###end p 54
###begin title 55
Statistical analyses.
###end title 55
###begin p 56
###xml 0 1 0 1 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 64 68 64 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 68 71 68 71 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 102 106 102 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 106 109 106 109 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/&#8722;</sup>
t tests were performed to assess the significance of changes in TAK1-/- group data compared with both TAK1+/- and WT groups.
###end p 56
###begin title 57
Online supplemental material.
###end title 57
###begin p 58
###xml 56 60 56 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 60 63 60 63 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 92 96 92 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 185 189 185 189 <italic xmlns:xlink="http://www.w3.org/1999/xlink">TAK1</italic>
###xml 189 192 189 192 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#8722;/&#8722;</sup>
###xml 64 68 <span type="species:ncbi:10090">mice</span>
###xml 216 220 <span type="species:ncbi:10090">mice</span>
Fig. S1 shows reduction of BM-nucleated cell numbers in TAK1-/- mice after the induction of TAK1 deletion. Fig. S2 shows analyses of the percentage of mature hematopoietic cells in the TAK1-/- and littermate control mice. Figs. S1 and S2 are available at .
###end p 58
###begin title 59
Supplementary Material
###end title 59
###begin title 60
[Supplemental Material Index]
###end title 60
###begin p 61
We appreciate the excellent animal care services provided by the staff of the Department of Comparative Medicine at Loyola University Medical Center. Ms. Patricia Simms helped with flow cytometric sorting of HSCs and progenitors, as well as in the analysis of flow cytometry data. We appreciate the ongoing professional collaborations of Drs. Nancy Zeleznik-Le and Andrew Dingwall, whose scientific suggestions and discussions improved the present studies.
###end p 61
###begin p 62
P. Breslin is supported in part by a grant from the Jimmy Burns Foundation.
###end p 62
###begin p 63
The authors have no conflicting financial interests.
###end p 63

